ORTHOPEDIATRICS CORP (KIDS) — SEC Financial Statements & Analysis

ORTHOPEDIATRICS CORP (KIDS) is a surgical & medical instruments & apparatus company. ORTHOPEDIATRICS CORP trades on Nasdaq as: KIDS. ORTHOPEDIATRICS CORP (KIDS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, ORTHOPEDIATRICS CORP carries a market cap of $460.05M, a P/E ratio of -11.58x, a P/B ratio of 1.34x, a P/S ratio of 1.82x, an enterprise value of $489.80M, and an EV/EBITDA multiple of -63.82x. On profitability, it posts a gross margin of 73.65%, an operating margin of -11.87%, a net margin of -15.72%, a Return on Equity (ROE) of -11.36%, a Return on Assets (ROA) of -7.83%, and a Return on Invested Capital (ROIC) of -8.11%. Per share, it reports EPS of $-1.65, diluted EPS of $-1.65, free cash flow per share of $-0.08, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 14.49% year-over-year, net income growth of -4.87% year-over-year, and EPS growth of -7.20% year-over-year. On the balance sheet, it maintains a current ratio of 4.78x, a quick ratio of 2.06x, working capital of $199.66M, a debt-to-equity ratio of 0.49x, a debt ratio of 0.33, an interest coverage ratio of -3.58x, free cash flow of $-1.83M (TTM), and net debt of $29.75M. Figures sourced from SEC EDGAR.

Market Cap

$460.05M

P/E TTM

-11.58x

EPS TTM

$-1.65

P/B TTM

1.34x

ROE TTM

-11.36%

ROA TTM

-7.83%

Debt To Equity

0.49x

Free Cash Flow TTM

$-1.83M

Net Revenue TTM Growth 1Y

14.49%

Data as of 2026-06-30 · Source: SEC EDGAR